Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 16 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-16-2024-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Zydus receives Final Approval from the USFDA for Isosorbide Mononitrate Extended-Release, Tablets USP, 30 mg, 60 mg, and 120 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases